Crossmark Global Holdings, Inc. - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 232 filers reported holding GENMAB A/S in Q4 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$2,616
-16.0%
73,813
+0.2%
0.06%
-11.9%
Q2 2023$3,113
+22.8%
73,678
+9.8%
0.07%
+11.7%
Q1 2023$2,534
-1.3%
67,104
+10.8%
0.06%
-6.2%
Q4 2022$2,567
-99.9%
60,559
-4.6%
0.06%
+12.3%
Q3 2022$2,039,000
+1.7%
63,483
+2.9%
0.06%
+9.6%
Q2 2022$2,004,000
-8.3%
61,670
+2.1%
0.05%
+6.1%
Q1 2022$2,185,000
-5.6%
60,400
+3.3%
0.05%
-2.0%
Q4 2021$2,314,000
-2.4%
58,490
+7.7%
0.05%
-10.7%
Q3 2021$2,372,000
+12.4%
54,290
+5.1%
0.06%
+12.0%
Q2 2021$2,110,000
+13.3%
51,680
-8.9%
0.05%
+8.7%
Q1 2021$1,863,000
-21.7%
56,740
-3.1%
0.05%
-23.3%
Q4 2020$2,380,000
+10.9%
58,545
-0.2%
0.06%0.0%
Q3 2020$2,147,000
+7.6%
58,635
-0.4%
0.06%
+3.4%
Q2 2020$1,995,000
+77.2%
58,875
+10.8%
0.06%
+45.0%
Q1 2020$1,126,000
+14.1%
53,160
+20.3%
0.04%
+48.1%
Q4 2019$987,00044,2000.03%
Other shareholders
GENMAB A/S shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 242,848$9,169,9403.80%
Capricorn Fund Managers Ltd 110,643$4,177,8801.28%
Arlington Capital Management, Inc. 35,591$1,343,9161.26%
XY Capital Ltd 76,884$2,903,1401.13%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 88,000$3,322,8800.93%
TORRAY INVESTMENT PARTNERS LLC 110,807$4,184,0720.75%
Hardman Johnston Global Advisors LLC 585,139$22,094,8490.72%
Yorktown Management & Research Co Inc 16,600$626,8160.68%
First Light Asset Management, LLC 160,025$6,042,5440.54%
MIRABELLA FINANCIAL SERVICES LLP 28,260$2,505,8550.38%
View complete list of GENMAB A/S shareholders